|
$47,500
|
To develop educational materials to highlight common patent abuse tactics used to keep lower costs generics and biosimilar products out of the marketplace and improve consumer and stakeholder understanding of drug pricing issues ripe for reform.
|
2022 - 2023
|
LJAF
|
|
$28,147
|
To educate the public and media about the impact of consolidated health care markets
|
2022
|
LJAF
|
